Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CosmoFer versus oral iron with epoietin for anemia in hematologic malignancies
2007-005777-57Phase 4Terminated
- Sponsor
- Henry Dunant Hospital Center
- Start
- Jan 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of iron sucrose, ferroglycine sulfate and Epoetin alfa RB in iron deficiency anemia (IDA) (2 arms), sponsored by Henry Dunant Hospital Center. Primary endpoints: Primary efficacy endpoint and Iron store repletion. Started Jan 2008; status: terminated.
02
Drugs
iron sucroseferroglycine sulfateEpoetin alfa RB
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2007-005777-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005777-57.